The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan.

TitleF-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan.
Publication TypeJournal Article
Year of Publication2020
AuthorsSachpekidis, C., Exadaktylou P., Katsampoukas D., Moralidis E., & Arsos G.
JournalHell J Nucl Med
Volume23
Issue1
Pagination76-78
Date Published2020 Jan-Apr
ISSN1790-5427
Abstract

Peritoneal lymphomatosis, defined as the disseminated intraperitoneal lymphomatous infiltration, is a rare presentation usually of non-Hodgkin lymphoma and is associated with aggressive histological subtypes of the malignancy. Recently, the term "peritoneal super scan" has been introduced in positron emission tomography/computed tomography (PET/CT) in a patient with Burkitt lymphoma to describe hypermetabolic lymphomatous involvement of the entire peritoneum, leading to suppression of tracer uptake in organs with otherwise normally increased fluorine-18-fluorodeoxyglucose (F-FDG) uptake. Herein, we report on a patient with Burkitt lymphoma, initially presenting with a peritoneal super scan in PET/CT demonstrating complete metabolic response to R-CHOP (rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone) therapy.

DOI10.1967/s002449912006
Alternate JournalHell J Nucl Med
PubMed ID32222732

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.